Silverfin false false 31/12/2025 01/01/2025 31/12/2025 Dr Robert Mead 10/12/2018 Dr Zoe Mead 15/04/2022 07 October 2026 The principal activity of the Company during the financial year was the provision of gastroenterology and endoscopy services. 11719449 2025-12-31 11719449 bus:Director1 2025-12-31 11719449 bus:Director2 2025-12-31 11719449 2024-12-31 11719449 core:CurrentFinancialInstruments 2025-12-31 11719449 core:CurrentFinancialInstruments 2024-12-31 11719449 core:ShareCapital 2025-12-31 11719449 core:ShareCapital 2024-12-31 11719449 core:RetainedEarningsAccumulatedLosses 2025-12-31 11719449 core:RetainedEarningsAccumulatedLosses 2024-12-31 11719449 core:Vehicles 2024-12-31 11719449 core:OfficeEquipment 2024-12-31 11719449 core:ComputerEquipment 2024-12-31 11719449 core:Vehicles 2025-12-31 11719449 core:OfficeEquipment 2025-12-31 11719449 core:ComputerEquipment 2025-12-31 11719449 core:CurrentFinancialInstruments 9 2025-12-31 11719449 core:CurrentFinancialInstruments 9 2024-12-31 11719449 2025-01-01 2025-12-31 11719449 bus:FilletedAccounts 2025-01-01 2025-12-31 11719449 bus:SmallEntities 2025-01-01 2025-12-31 11719449 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 11719449 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 11719449 bus:Director1 2025-01-01 2025-12-31 11719449 bus:Director2 2025-01-01 2025-12-31 11719449 core:Vehicles 2025-01-01 2025-12-31 11719449 core:OfficeEquipment core:TopRangeValue 2025-01-01 2025-12-31 11719449 core:ComputerEquipment core:TopRangeValue 2025-01-01 2025-12-31 11719449 2024-01-01 2024-12-31 11719449 core:OfficeEquipment 2025-01-01 2025-12-31 11719449 core:ComputerEquipment 2025-01-01 2025-12-31 iso4217:GBP xbrli:pure

Company No: 11719449 (England and Wales)

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 December 2025
HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 December 2025
Note 2025 2024
£ £
Fixed assets
Tangible assets 3 29,024 36,029
29,024 36,029
Current assets
Debtors 4 8,563 14,849
Cash at bank and in hand 421,794 371,764
430,357 386,613
Creditors: amounts falling due within one year 5 ( 39,175) ( 41,371)
Net current assets 391,182 345,242
Total assets less current liabilities 420,206 381,271
Provision for liabilities ( 7,256) ( 9,007)
Net assets 412,950 372,264
Capital and reserves
Called-up share capital 100 100
Profit and loss account 412,850 372,164
Total shareholders' funds 412,950 372,264

For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of Hertfordshire and Bedfordshire Gastroenterology (HBG) Limited (registered number: 11719449) were approved and authorised for issue by the Board of Directors. They were signed on its behalf by:

Dr Robert Mead
Director

07 October 2026

HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
HERTFORDSHIRE AND BEDFORDSHIRE GASTROENTEROLOGY (HBG) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Hertfordshire and Bedfordshire Gastroenterology (HBG) Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 1 The Atrium Phoenix Square, Wyncolls Road, Colchester, CO4 9AS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is stated net of VAT and trade discounts and is recognised when the significant risks and rewards are considered to have been transferred to the buyer. Turnover from the supply of services represents the value of services provided under contracts to the extent that there is a right to consideration and is recorded at the fair value of the consideration received or receivable. Where a contract has only been partially completed at the reporting date turnover represents the fair value of the service provided to date based on the stage of completion of the contract activity at the reporting date. Where payments are received from customers in advance of services provided, the amounts are recorded as deferred income and included as part of creditors due within one year.

Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets is reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Vehicles 25 % reducing balance
Office equipment 4 years straight line
Computer equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Statement of Financial Position when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

2025 2024
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Vehicles Office equipment Computer equipment Total
£ £ £ £
Cost
At 01 January 2025 54,359 144 2,270 56,773
Additions 0 239 2,129 2,368
At 31 December 2025 54,359 383 4,399 59,141
Accumulated depreciation
At 01 January 2025 20,385 30 329 20,744
Charge for the financial year 8,493 46 834 9,373
At 31 December 2025 28,878 76 1,163 30,117
Net book value
At 31 December 2025 25,481 307 3,236 29,024
At 31 December 2024 33,974 114 1,941 36,029

4. Debtors

2025 2024
£ £
Trade debtors 7,443 12,431
Amounts owed by directors 135 381
Prepayments 856 1,908
S455 129 129
8,563 14,849

5. Creditors: amounts falling due within one year

2025 2024
£ £
Accruals 4,922 5,729
Taxation and social security 34,253 35,642
39,175 41,371

6. Related party transactions

At 1 January 2025 the directors owed the Company £381.

During the year advances of £30,731 were made to the directors. Interest was charged at the official rate and amounted to £723 for the year.

Amounts repaid by the directors during the year totalled £31,700.

At 31 December 2025 the directors owed the Company £135.